Kalahn Taylor-Clark

Kalahn Taylor-Clark, Ph.D., M.P.H.

President of Prevention Institute’s Board of Directors
Vice President and Head of Strategic Partnerships and Innovation, Myovant Sciences
San Francisco, CA

Kalahn Taylor-Clark, PhD, MPH is the Vice President and Head of Strategic Partnerships and Innovation at Myovant Sciences. Prior to this post, she served as both the US Head of Public Affairs in Cardiometabolic Health and as the Global Head of Patient Engagement Strategy at Sanofi, where she was the strategic lead for developing patient-centered engagement. Dr. Taylor-Clark’s work has helped the company to develop, measure, amplify and adapt solutions based on key stakeholder input (e.g. providers, patients, scientific societies, and policymakers). Prior to joining Sanofi, Dr. Taylor-Clark served as a Senior Advisor to the Center for Health Policy, Research and Ethics and Assistant Professor in Health Administration and Policy at George Mason University. Previously, she served as the Director of Health Policy at the National Partnership for Women and Families and led the Patient-Centeredness and Health Equity Portfolios in the Engelberg Center for Health Care Reform at the Brookings Institution. She holds a BA in International Relations from Tufts University, an MPH from Tufts School of Medicine, and a PhD in Health Policy from Harvard University. She serves as a Member of the Board of Trustees for Tufts University. She speaks French and has lived in Ghana, France, and Japan.